All In Biotech

Free tool

FAERS Monitor: Lamictal Odt

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022251 or its brand name (Lamictal Odt, Lamotrigine). Reports on generic versions are filed under their own applications.

Reports

131,818

Serious

95,257

72% of reports

Hospitalization

40,669

Death reported

11,489

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,339
  • rash8,692
  • seizure6,714
  • nausea6,457
  • off label use6,296
  • fatigue6,266
  • dizziness6,077
  • headache5,815
  • depression5,273
  • vomiting4,850
  • somnolence4,542
  • pyrexia4,522
  • drug interaction4,517
  • anxiety4,499
  • toxicity to various agents4,368

Reports by year received

View as table
YearReports
20042,016
20053,052
20063,557
20073,880
20082,377
20094,889
20103,761
20114,928
20125,259
20134,636
20145,129
20157,174
20167,478
20177,208
20188,199
20198,580
20207,704
20217,243
20226,632
20236,990
20247,677
20257,874
20265,574

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,922,341 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal6,7149.89.650,146
drug interactionSignal4,5174.64.512,652
toxicity to various agentsSignal4,3684.24.110,520
depressionSignal5,2733.83.710,555
somnolenceSignal4,5423.73.68,660
rashSignal8,6923.23.213,360
anxietySignal4,4992.52.54,216
pyrexiaSignal4,5222.12.02,612
dizziness6,0772.01.92,871
vomiting4,8501.71.61,265
headache5,8151.51.4938
nausea6,4571.31.3472
fatigue6,2661.31.3411
drug ineffective10,3391.31.2562
off label use6,2961.11.1125

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.